Cytocentric measurement for regenerative medicine

Any Regenerative Medicine (RM) business requires reliably predictable cell and tissue products. Regulatory agencies expect control and documentation. However, laboratory tissue production is currently not predictable or well-controlled. Before conditions can be controlled to meet the needs of cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Henn, Alicia D., Pereira, Taci, Hunsberger, Joshua, Mitra, Kunal, Izadifar, Zohreh, Somara, Sita, Lindström, Lisa, Forest Farb-Horch, Thomas, Boy, Jake, Muschler, George F., Bauer, Steven R., Yerden, Randy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172495/
https://www.ncbi.nlm.nih.gov/pubmed/37181099
http://dx.doi.org/10.3389/fmedt.2023.1154653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172495/
https://www.ncbi.nlm.nih.gov/pubmed/37181099
http://dx.doi.org/10.3389/fmedt.2023.1154653

Ejemplares similares